• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Stocks That Hit 52-Week Lows On Friday

    7/28/23 12:36:40 PM ET
    $AADI
    $ABVC
    $ADAP
    $ADMP
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Get the next $AADI alert in real time by email

     

    Friday's session saw 59 companies set new 52-week lows.

    Interesting Facts About Today's 52-Week Lows:

    • Bristol-Myers Squibb (NYSE:BMY) was the largest firm by market cap to set a new 52-week low.
    • BitNile Metaverse (NASDAQ:BNMV) was the smallest company in terms of market cap to set a new 52-week low.
    • Tonix Pharmaceuticals (NASDAQ:TNXP) saw the largest move of the companies, as shares plummetted 38.2% to hit a new 52-week low.
    • ClearPoint Neuro (NASDAQ:CLPT)'s stock bounced back the most, actually rising 0.0% after reaching its new 52-week low.

    The following stocks created new 52-week lows on Friday:

    • Bristol-Myers Squibb (NYSE:BMY) shares were up 0.07% for the day, having made a 52-week low of $60.05.
    • TC Energy (NYSE:TRP) shares were down 4.72% for the day, having made a 52-week low of $33.05.
    • Enphase Energy (NASDAQ:ENPH) shares were down 10.61% for the day, having made a 52-week low of $145.67.
    • Apellis Pharmaceuticals (NASDAQ:APLS) shares made a new 52-week low of $27.90 on Friday. The stock was down 5.79% for the day.
    • NovoCure (NASDAQ:NVCR) shares set a new 52-week low of $32.51. The stock traded down 2.86%.
    • Clearway Energy (NYSE:CWEN) stock hit a yearly low of $26.30. The stock was down 0.26% for the day.
    • TELUS Intl (NYSE:TIXT) shares set a new 52-week low of $9.31. The stock traded down 0.21%.
    • Impinj (NASDAQ:PI) stock hit a new 52-week low of $65.47. The stock was down 5.13% on the session.
    • Maravai LifeSciences (NASDAQ:MRVI) stock broke to a new 52-week low of $11.12 on Friday. Shares of the company traded up 0.39%.
    • Baijiayun Group (NASDAQ:RTC) shares fell to $6.29 on Friday, setting a new 52-week low with a shift of up 3.69%.
    • 2seventy bio (NASDAQ:TSVT) stock achieved a new 52-week low on Friday morning, hitting $7.46 and moving down 7.08%.
    • Emergent BioSolutions (NYSE:EBS) shares set a new 52-week low of $6.72. The stock traded up 0.87%.
    • TPI Composites (NASDAQ:TPIC) shares reached a new 52-week low of $5.56 on Friday morning, moving down 6.52%.
    • Prelude Therapeutics (NASDAQ:PRLD) stock hit $3.96 on Friday morning, setting a new 52-week low for a change of down 3.12%.
    • Rimini Street (NASDAQ:RMNI) stock set a new 52-week low of $2.26 on Friday, moving down 2.33%.
    • Adaptimmune Therapeutics (NASDAQ:ADAP) shares moved up 2.56% on Friday to hit a new 52-week low of $0.87, drifting up 2.56%.
    • NGM Biopharmaceuticals (NASDAQ:NGM) stock drifted down 0.44% on Friday morning to hit a new 52-week low of $2.23.
    • Nouveau Monde Graphite (NYSE:NMG) stock set a new 52-week low of $2.73 on Friday, moving down 4.83%.
    • Complete Solaria (NASDAQ:CSLR) shares set a new yearly low of $3.50 this morning. The stock was down 1.87% on the session.
    • ClearPoint Neuro (NASDAQ:CLPT) shares set a new 52-week low of $6.25. The stock traded 0.0% (flat).
    • Electrovaya (NASDAQ:ELVA) stock set a new 52-week low of $4.11 on Friday, moving down 3.17%.
    • NioCorp Developments (NASDAQ:NB) stock hit $4.35 on Friday morning, setting a new 52-week low for a change of up 1.37%.
    • Aadi Bioscience (NASDAQ:AADI) stock hit a yearly low of $5.17. The stock was down 3.35% for the day.
    • G1 Therapeutics (NASDAQ:GTHX) stock set a new 52-week low of $2.31 on Friday, moving up 1.29%.
    • Eargo (NASDAQ:EAR) shares hit a yearly low of $3.88. The stock was up 2.31% on the session.
    • MSP Recovery (NASDAQ:LIFW) stock hit a new 52-week low of $0.20. The stock was up 10.04% on the session.
    • CEL-SCI (AMEX:CVM) shares hit a yearly low of $1.53. The stock was down 9.94% on the session.
    • Delta Apparel (AMEX:DLA) shares reached a new 52-week low of $8.71 on Friday morning, moving down 0.4%.
    • Airgain (NASDAQ:AIRG) stock hit a new 52-week low of $4.61. The stock was down 2.71% on the session.
    • Leap Therapeutics (NASDAQ:LPTX) stock set a new 52-week low of $2.26 on Friday, moving up 5.79%.
    • Phoenix New Media (NYSE:FENG) stock hit a yearly low of $1.63. The stock was down 6.78% for the day.
    • Strong Global (AMEX:SGE) shares hit a yearly low of $2.40. The stock was up 2.0% on the session.
    • Addentax Group (NASDAQ:ATXG) shares made a new 52-week low of $3.42 on Friday. The stock was down 0.83% for the day.
    • Tonix Pharmaceuticals (NASDAQ:TNXP) shares made a new 52-week low of $1.01 on Friday. The stock was down 38.2% for the day.
    • Golden Minerals (AMEX:AUMN) shares moved down 3.88% on Friday to hit a new 52-week low of $1.20, drifting down 3.88%.
    • China Jo-Jo Drugstores (NASDAQ:CJJD) shares set a new yearly low of $0.36 this morning. The stock was down 0.5% on the session.
    • Precipio (NASDAQ:PRPO) stock hit a new 52-week low of $0.31. The stock was down 0.25% on the session.
    • ABVC BioPharma (NASDAQ:ABVC) stock hit a yearly low of $2.61. The stock was down 14.19% for the day.
    • Powerbridge Technologies (NASDAQ:PBTS) stock drifted down 5.04% on Friday morning to hit a new 52-week low of $0.26.
    • Siyata Mobile (NASDAQ:SYTA) shares set a new 52-week low of $0.04. The stock traded down 7.05%.
    • Applied UV (NASDAQ:AUVI) stock drifted down 2.37% on Friday morning to hit a new 52-week low of $0.80.
    • TRACON Pharma (NASDAQ:TCON) shares fell to $0.26 on Friday, setting a new 52-week low with a shift of down 3.18%.
    • Micromobility com (NASDAQ:MCOM) stock hit a new 52-week low of $0.07. The stock was down 7.85% on the session.
    • FOXO Technologies (AMEX:FOXO) stock drifted up 0.89% on Friday morning to hit a new 52-week low of $0.13.
    • Lixte Biotech Hldgs (NASDAQ:LIXT) stock dropped to a yearly low on Friday of $3.23. Shares traded down 7.61%.
    • Bellerophon Therapeutics (NASDAQ:BLPH) stock set a new 52-week low of $0.39 on Friday, moving down 3.71%.
    • Adamis Pharmaceuticals (NASDAQ:ADMP) shares were down 7.41% for the day, having made a 52-week low of $1.45.
    • Ault Alliance (AMEX:AULT) stock set a new 52-week low of $2.78 on Friday, moving down 1.68%.
    • C3is (NASDAQ:CISS) stock hit $0.55 on Friday morning, setting a new 52-week low for a change of up 2.42%.
    • EBET (NASDAQ:EBET) shares set a new 52-week low of $0.08. The stock traded down 0.29%.
    • Gaucho Group Holdings (NASDAQ:VINO) shares set a new 52-week low of $0.48. The stock traded down 3.92%.
    • Kiromic BioPharma (NASDAQ:KRBP) stock hit a yearly low of $2.46. The stock was down 3.68% for the day.
    • Avalo Therapeutics (NASDAQ:AVTX) shares set a new 52-week low of $0.18. The stock traded down 9.71%.
    • G Medical Innovations (NASDAQ:GMVD) shares were down 14.96% for the day, having made a 52-week low of $0.27.
    • Ucommune International (NASDAQ:UK) shares set a new 52-week low of $0.33. The stock traded down 4.81%.
    • Esports Entertainment (NASDAQ:GMBL) shares made a new 52-week low of $0.41 on Friday. The stock was down 1.49% for the day.

    Be sure to monitor Benzinga for the news traders need! And for even more up-to-date info on 52-week lows and highs, check out Benzinga Pro. This cutting-edge market research platform alerts traders of which stocks are trading near their 52-week highs and lows each morning - and delivers lots of other actionable data. Learn more here.

    Get the next $AADI alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $AADI
    $ABVC
    $ADAP
    $ADMP

    CompanyDatePrice TargetRatingAnalyst
    Impinj Inc.
    $PI
    2/6/2026$112.00Outperform → In-line
    Evercore ISI
    Enphase Energy Inc.
    $ENPH
    2/4/2026$52.00Hold → Buy
    HSBC Securities
    Enphase Energy Inc.
    $ENPH
    2/4/2026$41.00Underperform → Market Perform
    BMO Capital Markets
    Enphase Energy Inc.
    $ENPH
    2/4/2026$54.00Sector Perform → Outperform
    RBC Capital Mkts
    Enphase Energy Inc.
    $ENPH
    2/4/2026$35.00 → $40.00Hold
    TD Cowen
    Avalo Therapeutics Inc.
    $AVTX
    2/2/2026$50.00Buy
    Guggenheim
    Apellis Pharmaceuticals Inc.
    $APLS
    1/28/2026$24.00Equal Weight
    Barclays
    Enphase Energy Inc.
    $ENPH
    1/22/2026$37.00Sell → Neutral
    Citigroup
    More analyst ratings

    $AADI
    $ABVC
    $ADAP
    $ADMP
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    President & CEO Kothandaraman Badrinarayanan bought $259,884 worth of shares (5,000 units at $51.98) (SEC Form 4)

    4 - Enphase Energy, Inc. (0001463101) (Issuer)

    2/5/26 4:41:25 PM ET
    $ENPH
    Semiconductors
    Technology

    SEC Form 4 filed by Chief Chemistry Officer Combs Andrew

    4 - Prelude Therapeutics Inc (0001678660) (Issuer)

    2/5/26 4:14:15 PM ET
    $PRLD
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Chief Executive Officer Francois Cedric exercised 8,840 shares at a strike of $3.76, increasing direct ownership by 2% to 490,837 units (SEC Form 4)

    4 - Apellis Pharmaceuticals, Inc. (0001492422) (Issuer)

    2/5/26 4:14:07 PM ET
    $APLS
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AADI
    $ABVC
    $ADAP
    $ADMP
    SEC Filings

    View All

    FOXO Technologies Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Financial Statements and Exhibits

    8-K - FOXO TECHNOLOGIES INC. (0001812360) (Filer)

    2/6/26 5:05:52 PM ET
    $FOXO
    Life Insurance
    Finance

    SEC Form 10-Q filed by NioCorp Developments Ltd.

    10-Q - NIOCORP DEVELOPMENTS LTD (0001512228) (Filer)

    2/6/26 4:36:49 PM ET
    $NB
    Metal Mining
    Basic Materials

    Amendment: SEC Form SCHEDULE 13G/A filed by Electrovaya Inc.

    SCHEDULE 13G/A - Electrovaya Inc. (0001844450) (Subject)

    2/6/26 1:05:57 PM ET
    $ELVA

    $AADI
    $ABVC
    $ADAP
    $ADMP
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Addentax Group Corp. Announces Proposed Acquisition of Artificial Intelligence (AI)-empowered and Crypto-enabled Asset Management Platform, with Potential to Generate Approximately HKD 300 Million in Revenue

    SHENZHEN, China, Feb. 6, 2026 /PRNewswire/ -- Addentax Group Corp. (NASDAQ:ATXG) (the "Company", "ATXG", "we", "us" or "our") today announced the proposed strategic acquisition of the offshore wealth management and integrated cross-border service business of Hong Kong-based Riches Group, a provider of global asset allocation and cross-border services. The Company believes that, if completed, the proposed acquisition would support the Company's global expansion strategy by facilitating the integration of Riches Group's offshore business ecosystem, AI-enabled financial solutions, and digital currency/crypto service offerings. Based on preliminary internal estimates and subject to final closing

    2/6/26 9:20:00 AM ET
    $ATXG
    Professional Services
    Consumer Discretionary

    Impinj Reports Fourth Quarter and Full Year 2025 Financial Results

    Impinj, Inc. (NASDAQ:PI), a leading RAIN RFID provider and Internet of Things pioneer, today released its financial results for the fourth quarter and year ended December 31, 2025. "2025 was a transition year for Impinj. We grew year-over-year endpoint IC volumes, made M800 our volume runner, launched Gen2X and exited the year with record adjusted EBITDA and cash," said Chris Diorio, Impinj co-founder and CEO. "As we continue driving our bold vision, I remain confident in our market position and energized by the opportunities ahead." Fourth Quarter 2025 Financial Summary Revenue of $92.8 million GAAP gross margin of 51.8%; non-GAAP gross margin of 54.5% GAAP net loss of $1.1 mi

    2/5/26 4:15:00 PM ET
    $PI
    Industrial Machinery/Components
    Technology

    The $71 Billion Cancer Shift: Why The FDA Is Speeding Up

    VANCOUVER, British Columbia, Feb. 05, 2026 (GLOBE NEWSWIRE) -- Equity-Insider.com News Commentary – The market is waking up to a $71 billion reality[1]. We are seeing a decisive move away from broad chemotherapy and toward precision biologics like mRNA and oncolytic viruses. The FDA is actively accelerating this cycle, having granted multiple breakthrough designations in January 2026 alone for platforms that demonstrate genuine survival durability[2]. This structural realignment positions Oncolytics Biotech Inc. (NASDAQ:ONCY), Moderna (NASDAQ:MRNA), Immunome (NASDAQ:IMNM), Autolus Therapeutics (NASDAQ:AUTL), and Prelude Therapeutics (NASDAQ:PRLD) within the emerging biological innovation c

    2/5/26 9:26:03 AM ET
    $AUTL
    $IMNM
    $MRNA
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care
    Biotechnology: Pharmaceutical Preparations

    $AADI
    $ABVC
    $ADAP
    $ADMP
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    President & CEO Kothandaraman Badrinarayanan bought $259,884 worth of shares (5,000 units at $51.98) (SEC Form 4)

    4 - Enphase Energy, Inc. (0001463101) (Issuer)

    2/5/26 4:41:25 PM ET
    $ENPH
    Semiconductors
    Technology

    Chief Executive Officer Kersten Geert R bought $200,001 worth of shares (38,023 units at $5.26), increasing direct ownership by 46% to 120,815 units (SEC Form 4)

    4 - CEL SCI CORP (0000725363) (Issuer)

    1/26/26 8:23:27 AM ET
    $CVM
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Amendment: Chief Operating Officer Sabet Ahmed Zaki bought $468 worth of shares (20 units at $23.40), increasing direct ownership by 2% to 1,015 units (SEC Form 4)

    4/A - Precipio, Inc. (0001043961) (Issuer)

    1/20/26 4:22:27 PM ET
    $PRPO
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    $AADI
    $ABVC
    $ADAP
    $ADMP
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Impinj downgraded by Evercore ISI with a new price target

    Evercore ISI downgraded Impinj from Outperform to In-line and set a new price target of $112.00

    2/6/26 8:09:28 AM ET
    $PI
    Industrial Machinery/Components
    Technology

    Enphase Energy upgraded by HSBC Securities with a new price target

    HSBC Securities upgraded Enphase Energy from Hold to Buy and set a new price target of $52.00

    2/4/26 10:18:44 AM ET
    $ENPH
    Semiconductors
    Technology

    Enphase Energy upgraded by BMO Capital Markets with a new price target

    BMO Capital Markets upgraded Enphase Energy from Underperform to Market Perform and set a new price target of $41.00

    2/4/26 8:24:40 AM ET
    $ENPH
    Semiconductors
    Technology

    $AADI
    $ABVC
    $ADAP
    $ADMP
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    November 14, 2024 - FDA Approves First Gene Therapy for Treatment of Aromatic L-amino Acid Decarboxylase Deficiency

    For Immediate Release: November 14, 2024 The U.S. Food and Drug Administration approved Kebilidi (eladocagene exuparvovec-tneq), an adeno-associated virus vector-based gene therapy indicated for the treatment of adult and pediatric patients with aromatic L-amino acid decarboxylase (AADC) deficiency. Kebilidi is the first FDA-approved gene therapy for treatment of AADC deficiency. “Clinical advancements in the f

    11/14/24 8:50:18 AM ET
    $CLPT
    $PTCT
    Medical/Dental Instruments
    Health Care
    Biotechnology: Pharmaceutical Preparations

    October 18, 2024 - FDA Roundup: October 18, 2024

    For Immediate Release: October 18, 2024 Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency:  This week, FDA continues ongoing efforts to increase access and supply of IV and peritoneal dialysis (PD) fluids following Hurricane Helene-related damage to Baxter International Inc.’s facility in Marion, North Carolina. Specifically, FDA acted quickly to c

    10/18/24 4:16:25 PM ET
    $NVCR
    $BAX
    Medical/Dental Instruments
    Health Care

    September 26, 2024 - FDA Approves Drug with New Mechanism of Action for Treatment of Schizophrenia

    For Immediate Release: September 26, 2024 Today, the U.S. Food and Drug Administration approved Cobenfy (xanomeline and trospium chloride) capsules for oral use for the treatment of schizophrenia in adults. It is the first antipsychotic drug approved to treat schizophrenia that targets cholinergic receptors as opposed to dopamine receptors, which has long been the standard of care.   “Schizophrenia is a leading

    9/26/24 6:42:20 PM ET
    $BMY
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AADI
    $ABVC
    $ADAP
    $ADMP
    Leadership Updates

    Live Leadership Updates

    View All

    TTM Technologies, Dutch Bros, Advanced Energy Industries, and American Healthcare REIT Set to Join S&P MidCap 400; Others to Join S&P SmallCap 600

    NEW YORK, Jan. 27, 2026 /PRNewswire/ -- S&P Dow Jones Indices will make the following changes to the S&P MidCap 400, S&P SmallCap 600: S&P SmallCap 600 constituent TTM Technologies Inc. (NASD: TTMI) will replace Civitas Resources Inc. (NYSE:CIVI) in the S&P MidCap 400, and Amneal Pharmaceuticals Inc. (NASD: AMRX) will replace TTM Technologies in the S&P SmallCap 600 effective prior to the opening of trading on Friday, January 30. S&P SmallCap 600 constituent SM Energy Co. (NYSE:SM) is acquiring Civitas Resources in a deal expected to be completed soon, pending final closing conditions. SM Energy will remain in the S&P SmallCap 600 post-merger.Dutch Bros Inc. (NYSE:BROS) will replace Potlatc

    1/27/26 6:02:00 PM ET
    $AEIS
    $AHR
    $AMRX
    Industrial Machinery/Components
    Technology
    Real Estate Investment Trusts
    Real Estate

    Airgain® Reports Granting of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)

    Airgain, Inc. (NASDAQ:AIRG), a leading provider of advanced wireless connectivity solutions, today announced that it has granted inducement awards to one new employee who recently joined the Company. The awards were made on December 15, 2025, under Airgain's 2021 Employment Inducement Incentive Award Plan, which provides for the granting of equity awards to new employees of Airgain as an inducement to join the company. The inducement awards to the new employee consist of an aggregate of 1,150 restricted stock units ("RSUs"). The RSUs shall vest over four years in substantially equal annual installments on December 15, 2026, 2027, 2028, and 2029, subject to the employee's continued service

    12/15/25 4:05:00 PM ET
    $AIRG
    Radio And Television Broadcasting And Communications Equipment
    Technology

    Tonix Pharmaceuticals Appoints Irina Ishak as General Counsel

    CHATHAM, N.J., Dec. 09, 2025 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP) ("Tonix" or the "Company"), a fully integrated commercial-stage biotechnology company today announced the appointment of Irina Ishak as General Counsel, effective December 8, 2025. Ms. Ishak will lead Tonix's legal, corporate governance, and compliance functions. "Irina is a highly accomplished corporate and commercial attorney whose experience spans public and private life sciences companies, as well as advising life sciences investors," said Seth Lederman, M.D., President and Chief Executive Officer of Tonix. "Her deep background in complex transactions, public company matters, and governa

    12/9/25 7:00:00 AM ET
    $TNXP
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AADI
    $ABVC
    $ADAP
    $ADMP
    Financials

    Live finance-specific insights

    View All

    Impinj Reports Fourth Quarter and Full Year 2025 Financial Results

    Impinj, Inc. (NASDAQ:PI), a leading RAIN RFID provider and Internet of Things pioneer, today released its financial results for the fourth quarter and year ended December 31, 2025. "2025 was a transition year for Impinj. We grew year-over-year endpoint IC volumes, made M800 our volume runner, launched Gen2X and exited the year with record adjusted EBITDA and cash," said Chris Diorio, Impinj co-founder and CEO. "As we continue driving our bold vision, I remain confident in our market position and energized by the opportunities ahead." Fourth Quarter 2025 Financial Summary Revenue of $92.8 million GAAP gross margin of 51.8%; non-GAAP gross margin of 54.5% GAAP net loss of $1.1 mi

    2/5/26 4:15:00 PM ET
    $PI
    Industrial Machinery/Components
    Technology

    Global Race for Critical Minerals Accelerates as Market Eyes $700B Opportunity by 2030

    NEW YORK, Feb. 05, 2026 (GLOBE NEWSWIRE) -- Market News Updates News Commentary - Critical minerals are becoming one of the most important building blocks of the global economy. Materials like lithium, nickel, cobalt, rare earth elements, and graphite are essential for electric vehicles, renewable energy systems, data centers, smartphones, and defense technologies. As the world shifts toward electrification and clean energy, demand for these minerals is rising quickly, making them a strategic priority for governments and a growing focus for investors while keeping watch on Active Companies that include: North American Niobium (OTCQB:NIOMF) (CSE:NIOB), NioCorp Developments Ltd. (NASDAQ:NB),

    2/5/26 8:45:00 AM ET
    $MP
    $NB
    Metal Mining
    Basic Materials

    Airgain Sets Fourth Quarter and Full Year 2025 Conference Call for Thursday, February 26, at 5:00 p.m. ET

    Airgain, Inc. (NASDAQ:AIRG), a leading provider of advanced wireless connectivity solutions, will hold a conference call on Thursday, February 26, 2026, at 5:00 p.m. Eastern time (2:00 p.m. Pacific time) to discuss its financial results for the fourth quarter and year ended December 31, 2025. Airgain management will host the presentation, followed by a question-and-answer period. Date: Thursday, February 26, 2026 Time: 5:00 p.m. Eastern time (2:00 p.m. Pacific time) Participant Dial-In: 877-407-2988 / +1 201-389-0923 or Call Me Event Confirmation #: 13757859 The conference call will be broadcast simultaneously and available for replay via the investor section of the company's website

    2/5/26 8:00:00 AM ET
    $AIRG
    Radio And Television Broadcasting And Communications Equipment
    Technology

    $AADI
    $ABVC
    $ADAP
    $ADMP
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by MSP Recovery Inc.

    SC 13D/A - MSP Recovery, Inc. (0001802450) (Subject)

    12/17/24 4:05:04 PM ET
    $LIFW
    EDP Services
    Technology

    Amendment: SEC Form SC 13G/A filed by Apellis Pharmaceuticals Inc.

    SC 13G/A - Apellis Pharmaceuticals, Inc. (0001492422) (Subject)

    11/22/24 4:16:13 PM ET
    $APLS
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form SC 13G filed by Apellis Pharmaceuticals Inc.

    SC 13G - Apellis Pharmaceuticals, Inc. (0001492422) (Subject)

    11/22/24 8:47:59 AM ET
    $APLS
    Biotechnology: Pharmaceutical Preparations
    Health Care